Filing Overview
Inventiva S.A. filed a Form 6-K on November 10, 2021 as a foreign private issuer. The filing covers the month of November 2021 and incorporates by reference Exhibit 99.1, a press release dated November 10, 2021. The submitted text includes the Form 6-K cover page but does not include the press release content.
Financial Metrics
The filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, cash balance, or other financial metrics.
Material Changes
The filing text does not describe material changes versus a prior comparable period. Any such information may be contained in the referenced Exhibit 99.1, which is not included in the provided text.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, outlook, management commentary, risk updates, contingencies, clinical developments, financing information, or unusual items. The filing identifies Frédéric Cren as Chief Executive Officer and is signed on behalf of Inventiva S.A.
Investor Verification Items
- Obtain and review Exhibit 99.1, the November 10, 2021 press release.
- Verify whether the press release contains financial results, clinical or regulatory updates, financing activity, or revised guidance.
- Confirm any reported cash runway, debt, liquidity, and funding requirements in the complete filing materials.